Drug Master Files for: imipramine pamoate
✉ Email this page to a colleague
imipramine pamoate Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
14150 | I | II | 5/21/1999 | SCHWIEZERHALL DEVELOPMENT CO | IMIPRAMINE PAMOATE |
15359 | I | II | 3/29/2001 | PISGAH LABS INC | IMIPRAMINE PAMOATE |
17665 | I | II | 9/10/2004 | TEVA PHARMACEUTICAL INDUSTRIES LTD | TRIMIPRAMINE MALEATE |
1778 | I | 8/10/1971 | ACETO CHEMICAL CO INC | IMIPRAMINE HCL IN BULK | |
18801 | I | II | 9/2/2005 | R L FINE CHEM | IMIPRAMINE PAMOATE |
1906 | A | II | 3/8/1972 | TEVA PHARMACEUTICAL INDUSTRIES LTD | IMIPRAMINE HYDROCHLORIDE USP |
1913 | I | II | 4/5/1972 | LUNDBECK PHARMACEUTICALS ITALY SPA | IMIPRAMINE HYDROCHLORIDE |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information